Literature DB >> 24133589

Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer.

Fen Yun1, Yongfeng Jia, Xiuxia Li, Li Yuan, Qinnuan Sun, Huiling Yu, Lin Shi, Hongwei Yuan.   

Abstract

A high frequency of mutations at the PTEN locus has been noticed in carcinoma of lung. However, the role of PTEN alternations and its association with outcome variables in the genesis of lung carcinoma are not understood fully. The purpose of our study was to examine the impact of EGFR, TGF-α, P-AKT and PTEN in the genesis of non-small cell lung cancer (NSCLC). Total numbers of 66 histopathologically confirmed cases of NSCLC and 10 cases of benign control samples embedded with wax were studied. We assessed EGFR, TGF-α and P-AKT by the use of specific antibody through immunohistochemistry as directed by the manufacturer, and detected PTEN expression by in situ hybridization. There were progressive loss of PTEN expression and significant increasing in EGFR, TGF-α, P-AKT expression from benign samples to NSCLC (p<0.05). The overexpression of EGFR, TGF-α, P-AKT and loss of PTEN expression were correlated to differentiation extent of cancer tissue, metastasis of lymph nodes and histological classification. Thus, alteration of EGFR, TGF-α, P-AKT and PTEN are likely important molecular events in pathogenesis and carcinogenesis of NSCLC.

Entities:  

Keywords:  EGFR; Non-small cell lung cancer (NSCLC); P-AKT; PTEN; TGF-α

Mesh:

Substances:

Year:  2013        PMID: 24133589      PMCID: PMC3796233     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.

Authors:  Antje Krohn; Tobias Diedler; Lia Burkhardt; Pascale-Sophie Mayer; Colin De Silva; Marie Meyer-Kornblum; Darja Kötschau; Pierre Tennstedt; Joseph Huang; Clarissa Gerhäuser; Malte Mader; Stefan Kurtz; Hüseyin Sirma; Fred Saad; Thomas Steuber; Markus Graefen; Christoph Plass; Guido Sauter; Ronald Simon; Sarah Minner; Thorsten Schlomm
Journal:  Am J Pathol       Date:  2012-06-13       Impact factor: 4.307

2.  Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.

Authors:  Vera Lucia Pannain; José Rodrigo Morais; Osmar Damasceno-Ribeiro; Venâncio Avancini-Alves
Journal:  Ann Hepatol       Date:  2012 Jul-Aug       Impact factor: 2.400

3.  The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.

Authors:  C Ghiţă; I D Vîlcea; M Dumitrescu; Alina Maria Vîlcea; C S Mirea; Mariana Aşchie; Florina Vasilescu
Journal:  Rom J Morphol Embryol       Date:  2012       Impact factor: 1.033

4.  PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.

Authors:  B B Duman; B Sahin; A Acikalin; M Ergin; S Zorludemir
Journal:  J BUON       Date:  2013 Jan-Mar       Impact factor: 2.533

5.  Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome.

Authors:  Marcus Bettstetter; Sabina Berezowska; Gisela Keller; Axel Walch; Annette Feuchtinger; Julia Slotta-Huspenina; Marcus Feith; Enken Drecoll; Heinz Höfler; Rupert Langer
Journal:  Hum Pathol       Date:  2012-11-14       Impact factor: 3.466

6.  Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.

Authors:  Lin-Qiang Li; Xue-Lian Li; Lu Wang; Wei-Jie Du; Rui Guo; Hai-Hai Liang; Xue Liu; De-Sen Liang; Yan-Jie Lu; Hong-Li Shan; Hong-Chi Jiang
Journal:  Cell Physiol Biochem       Date:  2012-07-27

7.  Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

Authors:  D Dionysopoulos; K Pavlakis; V Kotoula; E Fountzilas; K Markou; I Karasmanis; N Angouridakis; A Nikolaou; K T Kalogeras; G Fountzilas
Journal:  Strahlenther Onkol       Date:  2013-02-13       Impact factor: 3.621

8.  Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L.

Authors:  Amélie Boespflug; Sébastien Couraud; Pierre-Paul Bringuier; Sylvie Isaac; Laurence Gérinière; Emilie Perrot; Patrick Edery; Isabelle Durieu; Pierre-Jean Souquet
Journal:  Lung Cancer       Date:  2012-12-20       Impact factor: 5.705

9.  Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma.

Authors:  Arshad Rahmani; Mohammad Alzohairy; Ali Yousif Babiker; Moshahid A Rizvi; Husain Gad Elkarimahmad
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

10.  Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.

Authors:  Seock-Ah Im; Kyung Eun Lee; Eunmi Nam; Do Yeun Kim; Joo-Ho Lee; Ho-Seong Han; Ju-Young Seoh; Hae-Young Park; Min-Sun Cho; Woon Sup Han; Soon Nam Lee
Journal:  Tumori       Date:  2005 Nov-Dec
View more
  9 in total

1.  Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment.

Authors:  Jun Zhang; Xiao-Ling Yu; Guo-Feng Zheng; Fei Zhao
Journal:  Med Oncol       Date:  2015-03-01       Impact factor: 3.064

2.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

3.  Cell penetrating peptide of sodium-iodide symporter effect on the I-131 radiotherapy on thyroid cancer.

Authors:  Yi-Xiang Fan; Zhi-Xin Liang; Qing-Zhu Liu; Han Xiao; Ke-Bin Li; Ji-Zhen Wu
Journal:  Exp Ther Med       Date:  2017-01-23       Impact factor: 2.447

4.  Expression of AKT and p-AKT protein in lung adenocarcinoma and its correlation with PD-L1 protein and prognosis.

Authors:  Zhi-Ying Hu; Wan-Yi Huang; Lei Zhang; Bo Huang; Shu-Chen Chen; Xiao-Ling Li
Journal:  Ann Transl Med       Date:  2020-09

5.  MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.

Authors:  Haijian Wu; Yan Liu; Xiao Ou Shu; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2016-03-31       Impact factor: 4.944

Review 6.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

7.  WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice.

Authors:  Chonji Fukumoto; Dai Nakashima; Atsushi Kasamatsu; Motoharu Unozawa; Tomomi Shida-Sakazume; Morihiro Higo; Katsunori Ogawara; Hidetaka Yokoe; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Oncoscience       Date:  2014-11-28

8.  Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.

Authors:  Liang Duan; Xuefei Hu; Yuxing Jin; Ruijun Liu; Qingjun You
Journal:  BMC Cancer       Date:  2016-04-18       Impact factor: 4.430

9.  Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-κB/Snail Signaling Pathway.

Authors:  Haihao Jin
Journal:  Comput Math Methods Med       Date:  2020-10-13       Impact factor: 2.238

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.